Back to Search
Start Over
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
- Source :
- Plus Company Updates. November 25, 2023
- Publication Year :
- 2023
-
Abstract
- SEOUL, South Korea: Dx&Vx has issued the following news release: DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix(OVM) by [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.775348144